Category Archives: Food & Drug Recalls

Voluntary Recall of Non Organic Gogo Squeez Applesauce Pouches

Materne North America Corp. (MNA) is voluntarily recalling specific packages of GoGo squeeZ® applesauce pouches due to potential adulteration from food product residue. The recalled applesauce pouches have a Best Before Date of 12/4/15-3/4/17 and a 5 digit production code beginning “US” followed by 01, 02, 03, 04, 05, 06, 07 or 08, which consumers can identify on the back of the pouch or on the bottom of the box, and “Product of USA” displayed under the Nutrition Facts Panel on the box.

Progressive Gourment Inc. Issues Alert on Sausage Egg Cheese Muffin Because of Possible Health Risk

Progressive Gourmet Inc. of Wilmington, MA, is recalling its 6 ounce packages of Sausage, Egg, and Cheddar Cheese on English Muffin breakfast sandwiches manufactured for Starbucks Coffee Co. out of the abundance of caution because they have the potential to be contaminated with Listeria monocytogenes. Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.

Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Fluconazole Injection, USP, (in 0.9% Sodium Chloride) 200mg per 100ml Due to the Discovery of an Out of Specification Impurity Result Detected During Routine Quality Testing of Stability Samples at the 18-Month Interval

Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of one lot of Fluconazole Injection, USP, (in 0.9% Sodium Chloride) 200mg per 100mL flexible container bag (NDC 25021-113-82) Lot 40608 manufactured by ACS Dobfar INFO S.A. and distributed by Sagent. Sagent has initiated this voluntary recall of Fluconazole Injection, USP, 200mg per 100mL to the user level due to the discovery of an out of specification impurity result detected during routine quality testing of stability samples at the 18-month interval.

FDA permits marketing of device that senses optimal time to check patient’s eye pressure

The U.S. Food and Drug Administration today allowed marketing of a one-time use contact lens that may help practitioners identify the best time of day to measure a patient’s intraocular pressure (IOP). Elevated IOP is often associated with the optic nerve damage that is characteristic of glaucoma.

FDA approves first coagulation factor-albumin fusion protein to treat patients with hemophilia B

The U.S. Food and Drug Administration today approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children and adults with Hemophilia B. Idelvion is the first coagulation factor-albumin fusion protein product to be approved, and the second Factor IX fusion protein product approved in the U.S. that is modified to last longer in the blood.